Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 125,718 | 75,470 | 58,642 | 100,808 | 110,991 |
| Marketable Securities | N/A | 39,315 | 53,780 | N/A | N/A |
| Receivables | 119,527 | 115,571 | 113,996 | 118,129 | 117,777 |
| Inventories | 169,376 | 172,541 | 172,469 | 171,261 | 181,430 |
| Income taxes - deferred | 64,575 | 62,264 | 36,285 | 36,155 | 37,800 |
| TOTAL | $493,562 | $477,323 | $459,743 | $452,257 | $476,328 |
| Non-Current Assets | |||||
| PPE Net | 161,189 | 146,928 | 136,770 | 131,383 | 122,435 |
| Intangibles | 510,771 | 516,393 | 526,152 | 530,102 | 538,463 |
| Other Non-Current Assets | 19,984 | 21,173 | 35,705 | 30,367 | 37,440 |
| TOTAL | $691,944 | $684,494 | $698,627 | $691,852 | $698,338 |
| Total Assets | $1,185,506 | $1,161,817 | $1,158,370 | $1,144,109 | $1,174,666 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 43,239 | 43,190 | 35,580 | 27,656 | 35,475 |
| Accrued Expenses | 65,690 | 64,796 | 64,979 | 69,669 | 65,329 |
| TOTAL | $112,574 | $112,247 | $104,586 | $101,868 | $104,433 |
| Non-Current Liabilities | |||||
| Long Term Debt | 321,875 | 321,875 | 166,875 | 179,688 | 192,500 |
| Deferred Revenues | 3,645 | 4,261 | 4,027 | 4,543 | 3,629 |
| Other Non-Current Liabilities | 209,463 | 211,159 | 372,960 | 364,189 | 367,598 |
| TOTAL | $546,231 | $542,358 | $545,333 | $549,603 | $568,712 |
| Total Liabilities | $658,805 | $654,605 | $649,919 | $651,471 | $673,145 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,091 | 54,066 | 54,032 | 53,760 | 53,642 |
| Common Shares | 359 | 359 | 358 | 357 | 359 |
| Retained earnings | 289,237 | 276,026 | 267,512 | 260,819 | 256,259 |
| Other shareholders' equity | -9,616 | -13,510 | -2,268 | -9,214 | -2,949 |
| TOTAL | $526,701 | $507,212 | $508,451 | $492,638 | $501,521 |
| Total Liabilities And Equity | $1,185,506 | $1,161,817 | $1,158,370 | $1,144,109 | $1,174,666 |